Serostim: A Promising Therapy for Muscular Dystrophy in American Males
Reading Time: 2 minutes Introduction to Muscular Dystrophy Muscular dystrophy (MD) encompasses a group of genetic disorders characterized by progressive muscle weakness and degeneration. Affecting approximately 250,000 individuals in the United States, MD poses significant challenges to patients, particularly American males who are more commonly affected by certain types such as Duchenne muscular dystrophy. The quest for effective treatments is ongoing, with Serostim emerging as a potential therapeutic agent. Understanding Serostim Serostim is a brand name for recombinant human growth hormone (rhGH), somatropin, which is produced using recombinant DNA technology. It is primarily used to treat growth failure in children and adults with growth...


